Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Titel:
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Auteur:
Fisher, Julie G. Tait, David Garrett-Mayer, Elizabeth Halabi, Susan Mangat, Pam K. Schink, Julian C. Alvarez, Ricardo H. Veljovich, Dan Cannon, Timothy L. Crilley, Pamela A. Pollock, Theodore Calfa, Carmen J. Al Baghdadi, Tareq Thota, Ramya Fleming, Nicole Cotta, Jared A. Rygiel, Andrew L. Warren, Sasha L. Schilsky, Richard L.